The FDA announced on March 10, 2023, that Inpeco S.A. is recalling its Storage and Retrieval Module (SRM)-Laboratory Automation systems due to firmware errors that may mis-associate sample IDs. This defect can lead to incorrect patient test results for sodium, potassium, and chloride levels.
How to tell if you have it
- Brand: Inpeco
- Product names: FlexLab (FLX), Accelerator a3600 (ACP), Aptio Automation (AP2)
- Part Numbers: ACP-207-00, ACP-207-01, ACP-230-00, ACP-230-01, APT-207-00, APT-207-01, APT-230-00, APT-230-01, FLX-207-00, FLX-207-01, FLX-207-02, FLX-230-00, FLX-230-01, FLX-230-02, FLX-207-10, FLX-207-11, FLX-230-10
- Firmware Versions: all versions
- Units affected: 245 in the US
The hazard
The firmware has the potential to mis-associate sample IDs, leading to incorrect or delayed patient results for sodium, potassium, and chloride. Falsely increased or decreased electrolytes can result in inappropriate treatment of normal results or failure to treat abnormal results. Abnormal potassium levels can result in weakness, polyuria, ileus, psychiatric disturbances, cardiac arrhythmias, respiratory depression, and death.
Context
GovInfoNow's records show Inpeco S.A. has 13 other recalls on record since 2018-02-13. Recent brand recalls include the 2025-10-30 Inpeco FlexLab FLX-217-1 recall for mismatched labels and the 2025-09-03 Inpeco FlexLab X Potassium Test System Recall for risk of erroneous results. Other recent recalls of similar products include the 2026-07-29 Nova Biomedical StatStrip Glucose Meter System Recalls for patient data mismatch risk and the 2026-06-08 Siemens Atellica CH A1c_E Test Recall for false HbA1c results risk.